Internal Server Error

About TL Ventures

TL Ventures is a venture capital firm founded in 1988. It is primarily based out of Wayne, United States. As of Aug 2015, TL Ventures has invested in 81 companies. It primarily invests in Series B round in United States based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to Life Sciences and Food and Agriculture Tech. Most recently it participated in the $***** Seed round of Tradiv Overall, TL Ventures portfolio has seen 1 unicorn, 4 IPOs and 38 acquisitions including key companies like iSpot.tv, Esperion Therapeutics and Northstar Group Services. A lot of funds co-invest with TL Ventures, with names like Canaan sharing a substantial percentage of its portfolio. TL Ventures has team of 13 people including 6 partners.
Key Metrics
Portfolio Locations
Rounds of Entry
Series A, Series B & 6 more
Portfolio Unicorns

TL Ventures' List of Top Investments

TL Ventures has a portfolio of 81 companies, one of which is a Unicorn. Their most notable investments are in Optichron and QuatRx.Their portfolio spans across United States, Australia, China and 4 more locations. They have invested in Enterprise Applications, Life Sciences, Food and Agriculture Tech and 22 other sectors, across stages such as Series A, Series B  and 6 more. Here is the list of top investments by TL Ventures:
Platform offering campaign analytics software. It provides digital analytics to the TV screen using cutting edge ACR technology. The platform provides brands with instant visibility into the delivery and reach of every ad on TV. It captures all the content and ads consumers view on smart Tvs across broadcast, cable, VOD, etc. It provides the results to advertisers and networks to evaluate and optimize ad investments. It offers a dashboard that enables users to drill into Tv ad activity by industry and specific brands.

Key facts about iSpot.tv

Developer of lipoprotein cholesterol (LDL-C) lowering therapies. Its drug pipeline includes Bempedoic Acid (ETC-1002) (Inhibitor of ATP Citrate Lyase) which is low-density lipoprotein cholesterol (LDL-C) lowering small molecule designed to lower elevated levels of LDL-C and to avoid side effects associated with existing LDL-C lowering therapies; ESP41091 and ApoA-1 Mimetics.

Key facts about Esperion Therapeutics

Key facts about Northstar Group Services

Provider of intent-based marketing and sales solutions. The platform offers solutions such as ABM optimization, sales enablement, contact center solutions, data analytics, sales funnel optimization, and others.

Key facts about Aberdeen

Cloud-based field service management suite solutions. It offers a resource management tool to control field operations. The features include RFID interfaced algorithm asset and location tracking, virtual cameras for digital evidence management, incident reporting, internal communication management, history tracker, etc. It also provides an alert system that notifies police of any accident or incident taking place on the field.

Key facts about Utility

TL Ventures' Investments by Stage

TL Ventures has made 18 investments in Series A stage with an average round size of $17M, 15 investments in Series B stage with an average round size of $18.1M and 8 investments in Series C stage with an average round size of $19.1M.
Here are TL Ventures' investments by stage:
Stage of entry
No. of Investments
Series A
18
Series B
15
Series C
8
Unattributed
4
Seed
3
Others
4
Breakdown of TL Ventures' investments by stage of entrySeries A (18)Series B (15)
Note: We have considered here, only first round of investments

TL Ventures' Investments by Sector

TL Ventures has a diverse portfolio, with companies operating in the Enterprise Applications, Life Sciences, Semiconductors, Business Services and Telecom. Notably, it has invested in 47 Enterprise (B2B) companies, 44 Tech companies, 24 Software companies and at least 11 companies focusing on Saas.
Here are TL Ventures' investments by sector:
Sector
No. of Investments
Enterprise Applications
16
Life Sciences
10
Semiconductors
10
Business Services
4
Telecom
4
Others
26
Breakdown of TL Ventures' investments by sectorsEnterprise Applic... (16)Life Sciences (10)
Note: We have considered here, only first round of investments

TL Ventures' Investments by Geography

TL Ventures has made most investments in United States (49), followed by Australia where it has made 1 investment.
Here are TL Ventures' investments by geography:
Country
No. of Investments
United States
49
Australia
1
China
1
Singapore
1
Breakdown of TL Ventures' investments by countriesUnited States (49)Australia (1)
Note: We have considered here, only first round of investments

TL Ventures' recent investments

TL Ventures has not made any investment in 2026 so far.
Here are the most recent investments by TL Ventures:
Date
Company
Location
Round Details
Round Amount
Co-Investors
Aug 07, 2015
United States
Seed
7860
Oct 08, 2013
United States
Series A
1504
Dec 13, 2012
China
Series A
5363
-
Jun 05, 2012
United States
Series A
7363
Apr 2012
United States
Series A
5688

Unicorns in TL Ventures' Portfolio

TL Ventures has 1 unicorn in its portfolio - iSpot.tv. The most recent unicorn in their portfolio is iSpot.tv which became a unicorn in 2022, 8 years after TL Ventures first invested in it.
Here is a list of unicorns in TL Ventures' portfolio:
Tracxn Score
Company
Short Description
Founded year
Sector
Location
Company Stage
First Investment/ Acquisition Details
69
Platform offering campaign analytics software
2012
Seattle
Series D
zugfnjc

IPOs and Publicly Listed companies in TL Ventures' Portfolio

4 of TL Ventures' portfolio companies have become public. Zalicus got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Nov 2005 and Epirus Biopharma got listed on the OTC Markets (OTCMKTS).
Here are TL Ventures' portfolio companies that went public:
Company
IPO Date
First Invested on
First Round of Investment
Round Size
Nov 09, 2005
Mar 10, 2004
Series C
7554
Nov 09, 2005
Mar 10, 2004
Series B
3029
Jun 09, 2000
-
-
6126
-
Aug 03, 2007
Series C
8471

Acquired companies in TL Ventures' Portfolio

38 companies from TL Ventures' portfolio have been acquired. The most recent acquisition was Esperion Therapeutics in May 2026 by ARCHIMED for $*****.
Here are TL Ventures' portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
May 01, 2026
Jan 13, 2000
Series A
8609
Aug 26, 2024
-
-
2172
Nov 13, 2023
Nov 14, 2000
Series C
7743
Jan 22, 2021
Jun 05, 2012
Series A
7085
Nov 23, 2020
Mar 19, 2001
Series B
6263

Team profile of TL Ventures

TL Ventures has a team of 13 members including 6 Partners located in United States and United Kingdom. TL Ventures' team does not sit on the board of any company as of now.
Here is a list of top team members in TL Ventures:
Name
Designation
Location
Board Memberships
Contact Details
Partner
United States
-
-
Partner
Philadelphia
-
-
Partner
Pittsburgh
-
-
Partner
-
-
-
Partner
Kansas City
-
-
Partner
Leeds
-
-

Co-investors of TL Ventures

Over the past 28 years, 212 investors have co-invested in TL Ventures's portfolio companies. This includes only funds.

Recent News related to TL Ventures

View all news related to TL Ventures

FAQs about TL Ventures

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford